Name of the inventor: Dezider Grunberger A method of inhibiting the formation of a cataract in an eye and a method of inhibiting the progression of cataract formation in an eye. The method of preventing a disease caused due to oxidative stress comprises..

Name of the inventor: Dezider Grunberger A method of inhibiting the formation of a cataract in an eye and a method of inhibiting the progression of cataract formation in an eye. The method of preventing a disease caused due to oxidative stress comprises administering to the subject a pharmaceutical composition comprising a pharmaceutically acceptable carrier and an effective oxidative stress-inhibiting compound. The method is useful in the treatment of rheumatoid arthritis, lupus, sickle cell anemia and cancer.

Pat. Title: INHIBITION OF CATARACT FORMATION, DISEASES RESULTING FROM OXIDATIVE STRESS, AND HIV REPLICATION BY CAFFEIC ACID ESTERS INHIBITION OF CATARACTS AND OTHER DISORDERS INHIBITION OF CATARACT FORMATION, DISEASES RESULTING FROM OXIDATIVE STRESS, & HIV REPLICATION BY CAFFEIC ACID ESTERS INHIBITION OF CATARACTS AND OTHER DISORDERS INHIBITION OF CATARACTS AND OTHER DISORDERS

Publication #: WO/1995/024899 AU9521229-A

App. #: 08/212,569 PCT/US95/03392 08/704,545 95 914 099.7 AU9521229-A

Patent #: 5,591,773 6313165

Licensing or sponsored research support